Recombinant multi-species MVP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MVP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the major component of the vault complex. Vaults are multi-subunit ribonucleoprotein structures that may be involved in nucleo-cytoplasmic transport. The encoded protein may play a role in multiple cellular processes by regulating the MAP kinase, JAK/STAT and phosphoinositide 3-kinase/Akt signaling pathways. The encoded protein also plays a role in multidrug resistance, and expression of this gene may be a prognostic marker for several types of cancer. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
The Alternative Names of target: 2310009M24Rik,LRP,Lung resistance-related protein,MVP,Major vault protein,Mvp,VAULT1

Target products collectionGo to MVP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IO106-Ag-1/ GM-Tg-hg-IO106-Ag-2 Human MVP protein Human
GM-Tg-rg-IO106-Ag-1/ GM-Tg-rg-IO106-Ag-2 Rat MVP protein Rat
GM-Tg-mg-IO106-Ag-1/ GM-Tg-mg-IO106-Ag-2 Mouse MVP protein Mouse
GM-Tg-cynog-IO106-Ag-1/ GM-Tg-cynog-IO106-Ag-2 Cynomolgus/Rhesus macaque MVP protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IO106-Ag-1/ GM-Tg-felg-IO106-Ag-2 Feline MVP protein Feline
GM-Tg-cang-IO106-Ag-1/ GM-Tg-cang-IO106-Ag-2 Canine MVP protein Canine
GM-Tg-bovg-IO106-Ag-1/ GM-Tg-bovg-IO106-Ag-2 Bovine MVP protein Bovine
GM-Tg-equg-IO106-Ag-1/ GM-Tg-equg-IO106-Ag-2 Equine MVP protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IO106-Ag-1/ GM-Tg-hg-IO106-Ag-2; GM-Tg-rg-IO106-Ag-1/ GM-Tg-rg-IO106-Ag-2;
GM-Tg-mg-IO106-Ag-1/ GM-Tg-mg-IO106-Ag-2; GM-Tg-cynog-IO106-Ag-1/ GM-Tg-cynog-IO106-Ag-2;
GM-Tg-felg-IO106-Ag-1/ GM-Tg-felg-IO106-Ag-2; GM-Tg-cang-IO106-Ag-1/ GM-Tg-cang-IO106-Ag-2;
GM-Tg-bovg-IO106-Ag-1/ GM-Tg-bovg-IO106-Ag-2; GM-Tg-equg-IO106-Ag-1/ GM-Tg-equg-IO106-Ag-2
Products Name MVP protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MVP
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MVP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.